(MKC) McCormick - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5797802064
Stock: Spices, Seasonings, Condiments, Sauces, Blends
Total Rating 28
Risk 69
Buy Signal -1.10
| Risk 5d forecast | |
|---|---|
| Volatility | 28.6% |
| Relative Tail Risk | -0.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.80 |
| Alpha | -21.76 |
| Character TTM | |
|---|---|
| Beta | 0.145 |
| Beta Downside | 0.499 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.82% |
| CAGR/Max DD | 0.01 |
EPS (Earnings per Share)
Revenue
Description: MKC McCormick February 28, 2026
McCormick & Company (NYSE: MKC) produces and distributes a broad portfolio of herbs, spices, seasoning blends, condiments, sauces, and desserts. The business is split into two segments: Consumer, which sells branded products such as McCormick, French’s, Frank’s RedHot, Lawry’s, Cholula, and Old Bay through grocery, mass-merchandise, club, discount, drug-store, and e-commerce channels; and Flavor Solutions, which supplies seasoning blends, coating systems, and compound flavors to multinational food manufacturers and food-service operators.
In FY 2023 the company generated $5.4 billion in net sales, with the Consumer segment contributing roughly 70 % of revenue. The latest Q2 2024 results showed a 5 % year-over-year organic sales increase to $1.35 billion and an operating margin of 13.2 %, while earnings per share rose to $4.80. Key drivers include sustained consumer demand for convenient, flavorful products, a pricing strategy that has historically outpaced inflation, and accelerating e-commerce penetration that now accounts for over 12 % of total sales.
For a deeper dive into MKC’s valuation metrics, you might explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 789.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.70 > 1.0 |
| NWC/Revenue: -13.51% < 20% (prev -11.06%; Δ -2.45% < -1%) |
| CFO/TA 0.07 > 3% & CFO 962.2m > Net Income 789.4m |
| Net Debt (3.90b) to EBITDA (1.28b): 3.04 < 3 |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (269.3m) vs 12m ago -0.15% < -2% |
| Gross Margin: 37.90% > 18% (prev 0.39%; Δ 3751 % > 0.5%) |
| Asset Turnover: 52.08% > 50% (prev 51.44%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 4.02 > 6 (EBITDA TTM 1.28b / Interest Expense TTM 196.2m) |
Altman Z'' 1.70
| A: -0.07 (Total Current Assets 2.14b - Total Current Liabilities 3.06b) / Total Assets 13.20b |
| B: 0.29 (Retained Earnings 3.82b / Total Assets 13.20b) |
| C: 0.06 (EBIT TTM 788.7m / Avg Total Assets 13.14b) |
| D: 0.77 (Book Value of Equity 5.74b / Total Liabilities 7.43b) |
| Altman-Z'' Score: 1.70 = BB |
Beneish M -2.96
| DSRI: 1.05 (Receivables 628.9m/587.4m, Revenue 6.84b/6.72b) |
| GMI: 1.02 (GM 37.90% / 38.54%) |
| AQI: 1.02 (AQ_t 0.73 / AQ_t-1 0.71) |
| SGI: 1.02 (Revenue 6.84b / 6.72b) |
| TATA: -0.01 (NI 789.4m - CFO 962.2m) / TA 13.20b) |
| Beneish M-Score: -2.96 (Cap -4..+1) = A |
What is the price of MKC shares?
As of March 04, 2026, the stock is trading at USD 67.67 with a total of 2,991,905 shares traded.
Over the past week, the price has changed by -3.33%, over one month by +6.92%, over three months by +6.28% and over the past year by -18.06%.
Over the past week, the price has changed by -3.33%, over one month by +6.92%, over three months by +6.28% and over the past year by -18.06%.
Is MKC a buy, sell or hold?
McCormick has received a consensus analysts rating of 3.44.
Therefor, it is recommend to hold MKC.
- StrongBuy: 4
- Buy: 1
- Hold: 9
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the MKC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.9 | 9.1% |
| Analysts Target Price | 73.9 | 9.1% |
MKC Fundamental Data Overview February 28, 2026
P/E Trailing = 23.6382
P/E Forward = 20.5339
P/S = 2.718
P/B = 3.2623
P/EG = 2.8511
Revenue TTM = 6.84b USD
EBIT TTM = 788.7m USD
EBITDA TTM = 1.28b USD
Long Term Debt = 3.11b USD (from longTermDebt, last quarter)
Short Term Debt = 890.5m USD (from shortTermDebt, last quarter)
Debt = 4.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.90b USD (from netDebt column, last quarter)
Enterprise Value = 22.49b USD (18.59b + Debt 4.00b - CCE 95.9m)
Interest Coverage Ratio = 4.02 (Ebit TTM 788.7m / Interest Expense TTM 196.2m)
EV/FCF = 25.60x (Enterprise Value 22.49b / FCF TTM 878.5m)
FCF Yield = 3.91% (FCF TTM 878.5m / Enterprise Value 22.49b)
FCF Margin = 12.84% (FCF TTM 878.5m / Revenue TTM 6.84b)
Net Margin = 11.54% (Net Income TTM 789.4m / Revenue TTM 6.84b)
Gross Margin = 37.90% ((Revenue TTM 6.84b - Cost of Revenue TTM 4.25b) / Revenue TTM)
Gross Margin QoQ = 38.93% (prev 37.40%)
Tobins Q-Ratio = 1.70 (Enterprise Value 22.49b / Total Assets 13.20b)
Interest Expense / Debt = 1.16% (Interest Expense 46.5m / Debt 4.00b)
Taxrate = 22.45% (65.6m / 292.2m)
NOPAT = 611.6m (EBIT 788.7m * (1 - 22.45%))
Current Ratio = 0.70 (Total Current Assets 2.14b / Total Current Liabilities 3.06b)
Debt / Equity = 0.70 (Debt 4.00b / totalStockholderEquity, last quarter 5.74b)
Debt / EBITDA = 3.04 (Net Debt 3.90b / EBITDA 1.28b)
Debt / FCF = 4.44 (Net Debt 3.90b / FCF TTM 878.5m)
Total Stockholder Equity = 5.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.01% (Net Income 789.4m / Total Assets 13.20b)
RoE = 14.03% (Net Income TTM 789.4m / Total Stockholder Equity 5.63b)
RoCE = 9.03% (EBIT 788.7m / Capital Employed (Equity 5.63b + L.T.Debt 3.11b))
RoIC = 6.17% (NOPAT 611.6m / Invested Capital 9.91b)
WACC = 5.47% (E(18.59b)/V(22.59b) * Re(6.45%) + D(4.00b)/V(22.59b) * Rd(1.16%) * (1-Tc(0.22)))
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.06%
[DCF] Terminal Value 87.40% ; FCFF base≈785.9m ; Y1≈881.1m ; Y5≈1.17b
[DCF] Fair Price = 120.9 (EV 34.56b - Net Debt 3.90b = Equity 30.66b / Shares 253.6m; r=5.90% [WACC]; 5y FCF grow 14.06% → 2.90% )
EPS Correlation: -10.47 | EPS CAGR: -42.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: 67.50 | Revenue CAGR: 5.34% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.72 | Chg7d=+0.004 | Chg30d=+0.004 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-11-30): EPS=3.10 | Chg7d=-0.001 | Chg30d=+0.005 | Revisions Net=-7 | Growth EPS=+3.3% | Growth Revenue=+14.8%
EPS next Year (2027-11-30): EPS=3.36 | Chg7d=+0.006 | Chg30d=+0.018 | Revisions Net=-5 | Growth EPS=+8.5% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +12.6% (Analyst 16.3% - Implied 3.7%)
P/E Forward = 20.5339
P/S = 2.718
P/B = 3.2623
P/EG = 2.8511
Revenue TTM = 6.84b USD
EBIT TTM = 788.7m USD
EBITDA TTM = 1.28b USD
Long Term Debt = 3.11b USD (from longTermDebt, last quarter)
Short Term Debt = 890.5m USD (from shortTermDebt, last quarter)
Debt = 4.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.90b USD (from netDebt column, last quarter)
Enterprise Value = 22.49b USD (18.59b + Debt 4.00b - CCE 95.9m)
Interest Coverage Ratio = 4.02 (Ebit TTM 788.7m / Interest Expense TTM 196.2m)
EV/FCF = 25.60x (Enterprise Value 22.49b / FCF TTM 878.5m)
FCF Yield = 3.91% (FCF TTM 878.5m / Enterprise Value 22.49b)
FCF Margin = 12.84% (FCF TTM 878.5m / Revenue TTM 6.84b)
Net Margin = 11.54% (Net Income TTM 789.4m / Revenue TTM 6.84b)
Gross Margin = 37.90% ((Revenue TTM 6.84b - Cost of Revenue TTM 4.25b) / Revenue TTM)
Gross Margin QoQ = 38.93% (prev 37.40%)
Tobins Q-Ratio = 1.70 (Enterprise Value 22.49b / Total Assets 13.20b)
Interest Expense / Debt = 1.16% (Interest Expense 46.5m / Debt 4.00b)
Taxrate = 22.45% (65.6m / 292.2m)
NOPAT = 611.6m (EBIT 788.7m * (1 - 22.45%))
Current Ratio = 0.70 (Total Current Assets 2.14b / Total Current Liabilities 3.06b)
Debt / Equity = 0.70 (Debt 4.00b / totalStockholderEquity, last quarter 5.74b)
Debt / EBITDA = 3.04 (Net Debt 3.90b / EBITDA 1.28b)
Debt / FCF = 4.44 (Net Debt 3.90b / FCF TTM 878.5m)
Total Stockholder Equity = 5.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.01% (Net Income 789.4m / Total Assets 13.20b)
RoE = 14.03% (Net Income TTM 789.4m / Total Stockholder Equity 5.63b)
RoCE = 9.03% (EBIT 788.7m / Capital Employed (Equity 5.63b + L.T.Debt 3.11b))
RoIC = 6.17% (NOPAT 611.6m / Invested Capital 9.91b)
WACC = 5.47% (E(18.59b)/V(22.59b) * Re(6.45%) + D(4.00b)/V(22.59b) * Rd(1.16%) * (1-Tc(0.22)))
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.06%
[DCF] Terminal Value 87.40% ; FCFF base≈785.9m ; Y1≈881.1m ; Y5≈1.17b
[DCF] Fair Price = 120.9 (EV 34.56b - Net Debt 3.90b = Equity 30.66b / Shares 253.6m; r=5.90% [WACC]; 5y FCF grow 14.06% → 2.90% )
EPS Correlation: -10.47 | EPS CAGR: -42.48% | SUE: -4.0 | # QB: 0
Revenue Correlation: 67.50 | Revenue CAGR: 5.34% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-05-31): EPS=0.72 | Chg7d=+0.004 | Chg30d=+0.004 | Revisions Net=-4 | Analysts=9
EPS current Year (2026-11-30): EPS=3.10 | Chg7d=-0.001 | Chg30d=+0.005 | Revisions Net=-7 | Growth EPS=+3.3% | Growth Revenue=+14.8%
EPS next Year (2027-11-30): EPS=3.36 | Chg7d=+0.006 | Chg30d=+0.018 | Revisions Net=-5 | Growth EPS=+8.5% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 7.9% - Earnings Yield 4.2%)
[Growth] Growth Spread = +12.6% (Analyst 16.3% - Implied 3.7%)